295 related articles for article (PubMed ID: 30207080)
1. BMI trajectories and risk of overall and grade-specific prostate cancer: An observational cohort study among men seen for prostatic conditions.
Wang K; Chen X; Gerke TA; Bird VY; Ghayee HK; Prosperi M
Cancer Med; 2018 Oct; 7(10):5272-5280. PubMed ID: 30207080
[TBL] [Abstract][Full Text] [Related]
2. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
Wang K; Gerke TA; Chen X; Prosperi M
Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
[TBL] [Abstract][Full Text] [Related]
3. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
[TBL] [Abstract][Full Text] [Related]
4. Association of Obesity or Weight Change With Coronary Heart Disease Among Young Adults in South Korea.
Choi S; Kim K; Kim SM; Lee G; Jeong SM; Park SY; Kim YY; Son JS; Yun JM; Park SM
JAMA Intern Med; 2018 Aug; 178(8):1060-1068. PubMed ID: 29913019
[TBL] [Abstract][Full Text] [Related]
5. Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.
Kelly SP; Lennon H; Sperrin M; Matthews C; Freedman ND; Albanes D; Leitzmann MF; Renehan AG; Cook MB
Int J Epidemiol; 2019 Apr; 48(2):464-473. PubMed ID: 30376043
[TBL] [Abstract][Full Text] [Related]
6. Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.
Lavalette C; Cordina Duverger E; Artaud F; Rébillard X; Lamy PJ; Trétarre B; Cénée S; Menegaux F
Cancer Med; 2020 Sep; 9(17):6421-6429. PubMed ID: 32639678
[TBL] [Abstract][Full Text] [Related]
7. Associations between Childhood Disadvantage and Adult Body Mass Index Trajectories: A Follow-Up Study among Midlife Finnish Municipal Employees.
Salmela J; Mauramo E; Lallukka T; Rahkonen O; Kanerva N
Obes Facts; 2019; 12(5):564-574. PubMed ID: 31484183
[TBL] [Abstract][Full Text] [Related]
8. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
Zheng R; Du M; Zhang B; Xin J; Chu H; Ni M; Zhang Z; Gu D; Wang M
Br J Cancer; 2018 Jul; 119(1):130-132. PubMed ID: 29872147
[TBL] [Abstract][Full Text] [Related]
9. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
10. General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada.
Vallières E; Mésidor M; Roy-Gagnon MH; Richard H; Parent MÉ
Cancer Causes Control; 2021 Jun; 32(6):653-665. PubMed ID: 33818663
[TBL] [Abstract][Full Text] [Related]
11. Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With Chemoradiotherapy.
Ma SJ; Khan M; Chatterjee U; Santhosh S; Hashmi M; Gill J; Yu B; Iovoli A; Farrugia M; Wooten K; Gupta V; McSpadden R; Yu H; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky E; Singh AK
JAMA Netw Open; 2023 Jun; 6(6):e2320513. PubMed ID: 37368400
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
[TBL] [Abstract][Full Text] [Related]
14. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
15. Lifetime Body Weight Trajectories and Risk of Renal Cell Cancer: A Large U.S. Prospective Cohort Study.
Deng Z; Hajihosseini M; Moore JX; Khan S; Graff RE; Bondy ML; Chung BI; Langston ME
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1651-1659. PubMed ID: 37624040
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer.
Loomans-Kropp HA; Umar A
JAMA Netw Open; 2023 May; 6(5):e2310002. PubMed ID: 37163267
[TBL] [Abstract][Full Text] [Related]
17. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
18. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category.
Jochems SHJ; Stattin P; Häggström C; Järvholm B; Orho-Melander M; Wood AM; Stocks T
Int J Cancer; 2020 Dec; 147(12):3328-3338. PubMed ID: 32525555
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?
Liang Y; Ketchum NS; Goodman PJ; Klein EA; Thompson IM
J Urol; 2014 Oct; 192(4):1094-9. PubMed ID: 24747090
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer.
Li D; Morris JS; Liu J; Hassan MM; Day RS; Bondy ML; Abbruzzese JL
JAMA; 2009 Jun; 301(24):2553-62. PubMed ID: 19549972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
